Chandhok’s $2.68 million sale sits inside a busy week


Circle Internet Group, Inc. is not being read in a vacuum here. The stock has been moving in a market that cares about interest rates, crypto volatility and whether stablecoin adoption can keep outrunning the old habit of treating this corner of finance as a trade, not an operating business. That is the frame. The filing is the detail inside it.
Chandhok, Circle’s chief product and technology officer, sold 26,666 shares on September 8 at $100.40 per share. The filing value was EUR 2,301,378, euro-normalised at ingest, and the reported gross sale total was $2,677,266. The trade followed an option exercise at $25.81, was executed under a pre-existing Rule 10b5-1 plan, and left him with 722,480 shares after the September 4 retention that started the tax holding period.
That is a real sale. It is also not a panic print. The plan was in place before the market saw the filing, and the retained share count matters more than the headline number if you are trying to separate routine monetisation from a genuine change in posture.
Circle lives at the intersection of two markets that can each distort the other. Stablecoin demand can rise with on-chain activity, but Circle’s economics still lean hard on reserve yields. That makes the stock unusually sensitive to the path of interest rates, even for a company that markets itself as infrastructure rather than a balance-sheet proxy.
The latest quarter showed why the name keeps drawing attention. USDC circulation reached $73.3 billion at the end of Q2 2026, up 19% year over year, while on-chain transaction volume surged 151% to $14.8 trillion. Those are not sleepy numbers. They tell you the product is moving through the system at scale, and they explain why the stock can trade like a hybrid of fintech, payments and rate-sensitive cash management.
Reserve income from interest on backing assets accounted for roughly 95% of Circle’s $701 million in total revenue and reserve income that quarter. That is the part that matters when you read the filing. A product chief selling stock under a 10b5-1 plan is one thing. A company whose revenue is still so concentrated in reserve income is another. If rates stay supportive, the market gives Circle more room. If they do not, the multiple has less to lean on.
Coinbase is the obvious comparison, but it is not a clean one. Coinbase’s revenue mix still leans on transaction fees, trading activity and the broader crypto cycle. Circle’s mix is more direct, more concentrated and more exposed to the yield on backing assets. Both names live in crypto infrastructure. They do not earn the same way, and the market should not price them as if they do.
That distinction matters because the sector has been rewarding anything that looks like durable crypto plumbing, then punishing it when the macro backdrop turns. Circle has also been helped by a series of company-specific catalysts. It received OCC approval for a national trust bank, and it has a scheduled September 16, 2026 mainnet launch for its Arc blockchain network. Those are the kinds of milestones that can keep the story in front of the market even when the broader crypto tape gets choppy.
The company also announced an all-stock acquisition of Singapore-based cross-border payments firm Tazapay, valued at $400 million, with regulatory approvals still needed, including from the Monetary Authority of Singapore, and closing expected in 2027. That is a longer-dated strategic move, not a near-term earnings lever. Still, it tells you Circle is trying to widen the use case beyond a single stablecoin narrative.
KBW initiated coverage with a Market Perform rating and a $105 price target, citing Circle’s positioning in stablecoin adoption. That sits close enough to the recent share price near $93 on September 10 to matter, but not so close that it removes the debate. The market is still deciding how much of the adoption story is already in the stock and how much is still ahead.

This is where the filing stops being a one-off and starts looking like a pattern. Circle has had six insiders trading the name in the same direction over the past quarter, and recent declarations include CFO Jeremy Fox-Geen, director Patrick Sean Neville, chief commercial officer Hossein Razzaghi, chief accounting officer Tamara Schulz and Chandhok himself. Similar activity also showed up in August.
Our scoring tends to reward that kind of configuration, especially when the trades come from operating insiders rather than a single outside director. The logic is simple enough. A lone sale can be housekeeping. A cluster across roles is harder to treat as noise, particularly when it arrives after a strong move and around a stock that has already re-rated on the back of product and regulatory progress.
Still, you should not overread the cluster. The filings do not all carry the same weight, and the presence of a 10b5-1 plan changes the tone of Chandhok’s sale. The plan tells you the trade was prearranged. It does not tell you whether the insider thinks the stock is rich, fairly valued or simply in the middle of a normal monetisation cycle after option exercise. You can infer discipline. You cannot infer a confession.
The size helps frame it. Chandhok’s sale was about 0.01% of the company’s market value, a small fraction in market-cap terms even if the dollar amount looks large on a screen. That is why the retained 722,480 shares matter. He did not walk away from the name. He trimmed into strength, under a plan, after exercising options at a much lower strike.
Circle’s fundamental profile is not pristine. InsiderTrades data puts the company’s fundamental score at 38, with a rank of 20,460 out of 29,063. The quality score is 36. Those are not disaster numbers, but they are not the kind of read that lets you ignore the revenue mix and move on. The business has scale, but the market is still paying for a story that depends on adoption, regulation and rates all cooperating at once.
That is why the reserve-income concentration matters more than the headline growth figures. When roughly 95% of revenue and reserve income comes from interest on backing assets, the company is not just a crypto story. It is a macro story with a crypto wrapper. If the rate path softens, the earnings power can compress faster than the user metrics suggest. If adoption keeps accelerating and the product stack widens, the market can keep paying up for the optionality.
The stock’s recent move near $93 after a post-earnings advance shows how quickly the market can reprice that optionality. It also shows why insider sales here are not automatically bearish. A stock that has already moved, a business with a concentrated revenue engine and a management team that has been active in the market can produce routine selling that looks ominous only if you ignore the rest of the setup.
InsiderTrades data’s historical cohort for director-level buys at mega-cap names shows a 90-day win rate of 47.2% across 5,280 samples, with an average 90-day return of 0.58% and an average 365-day return of 88.22%. That is historical cohort data for a role-and-size bucket, not a promise about Circle and not a forecast for Chandhok’s sale. It is useful because it keeps you honest about how much edge the filing itself really carries.
The cohort read is modest at the 90-day horizon. That should not surprise anyone who has spent time around insider data. Short windows are noisy, and the market often prices the obvious part of the filing before the rest of the information set has a chance to matter. The longer horizon looks better, but that is a function of the bucket, the sample and the regime, not a guarantee that this particular stock will follow the same path.
The strategy token set is there for readers who want the framework, but the caveat matters more than the headline. The out-of-sample figures live on a restricted EU venue universe, do not survive search-aware deflation, and the window is short and single-regime, so the tokenized headline should be read as a screen, not a promise. If you want the live framework, the token is 0.81, with 26.4 and 51.5 alongside it. That is enough to know the system exists. It is not enough to turn the filing into a backtest fantasy.
The company is still the same one it was before Chandhok sold. USDC circulation is still large, on-chain volume is still growing, and the Arc launch is still on the calendar for September 16. The Tazapay deal is still pending approvals. The stock is still sensitive to rates, crypto sentiment and whether the market keeps rewarding stablecoin infrastructure as a category.
What changes after a filing like this is the burden of proof. A six-insider cluster, a product chief sale under a 10b5-1 plan and a stock that has already had a post-earnings run do not force a bearish conclusion. They do tell you the easy version of the bull case is no longer enough. You need adoption to keep compounding, reserve income to stay supported and the market to keep believing Circle can widen beyond a single rate-driven revenue engine.
That is the practical read. Circle is still a name with real operating momentum, but the insider pattern says management is happy to sell into the strength that momentum has created. The next hard check is not another filing. It is whether the September 16 Arc launch lands cleanly, and whether the market keeps treating the company’s rate-linked revenue base as a feature rather than a ceiling.
Dig deeper: Chandhok Nikhil's filing track record.
This is not investment advice.
Circle CEO Jeremy Allaire sold EUR 6.1m in stock while USDC growth, crypto momentum and a Tazapay deal kept the story al...
Oklo insider selling clustered around a 10 GW AI-nuclear buildout. Here is how the September 8 filing reads against peer...
DocuSign’s CFO sold EUR 3.1m after a recent run lower. Read the filing against AI-driven SaaS peers, rates, and the stoc...
Delek director Vicky Sutil sold EUR 393,580 under a 10b5-1 plan while refining margins stay hot and peers keep ripping h...
Charles Collier sold 20,538 Roku shares for about EUR 3.22m while the Fox deal and CTV ad market keep the stock in focus...
Tarsus posted 69% XDEMVY growth, then three insiders sold in early September. Here is what the filings say against biote...